Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma. [electronic resource]
Producer: 20191112Description: 320-325 p. digitalISSN:- 1476-4180
- Administration, Cutaneous
- Adult
- Antifibrinolytic Agents -- administration & dosage
- Chemotherapy, Adjuvant
- Combined Modality Therapy
- Double-Blind Method
- Facial Dermatoses -- therapy
- Female
- Humans
- Lasers, Solid-State -- therapeutic use
- Male
- Melanosis -- therapy
- Middle Aged
- Patient Satisfaction
- Prospective Studies
- Severity of Illness Index
- Tranexamic Acid -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.